Jihoon E. Joo is an oncologist based in Parkville, VIC, working from 305 Grattan Street. Oncology is about caring for people with cancer, and it also means paying attention to what happens after treatment, and what support is needed along the way.
In many cases, Jihoon works with patients who have bowel cancers and other cancers across the body. This can include colorectal cancer, stomach cancer, prostate cancer, breast cancer, cervical cancer, endometrial cancer, urothelial cancer, and cancers that affect the brain. At times, care also includes blood cancers and other related conditions, like B-cell lymphoma.
Jihoon also looks after people who may have a higher risk of cancer due to inherited conditions. That can include Lynch syndrome and familial colorectal cancer, as well as familial adenomatous polyposis. There are also rarer inherited syndromes that come up in real life, like Turcot syndrome and mosaicism. When these are involved, the focus is often on getting the right screening plan and making sense of family risk, not just treating one tumour.
Cancer care is never one-size-fits-all. Some visits are about diagnosis and next steps. Others are about treatment planning, managing side effects, or coordinating tests. Over time, it can also be about making sure changes in symptoms are taken seriously and checked quickly.
Jihoon’s work includes supporting patients through complicated decision points. For example, choosing what tests to do, timing treatment around other health issues, and understanding what results mean. It can be a lot to take in, and the goal is to keep things clear and practical.
The doctor works in a team-based setting, which is common in cancer care. That means sharing information with other specialists and working together to plan treatment and follow-up.
At this practice, the focus stays on real-world care: listening, explaining options in plain language, and helping patients and families feel more steady as they go through treatment. If you’re dealing with cancer, or you’re worried about an inherited cancer risk, getting the right oncology input early can make a difference.